Gyre Therapeutics Ownership 2024 | Who Owns Gyre Therapeutics Now?
Institutional Ownership
0.00%
Insider Ownership
27.73%
Retail Ownership
72.26%
Institutional Holders
1.00
Gyre Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -7,052 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -22,484 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -201 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -86,412 | -100.00% | - | Dec 31, 2023 |
| STATE STREET CORP | - | - | - | -72,599 | -100.00% | - | Dec 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -206,900 | -100.00% | - | Dec 31, 2023 |
| JOHNSON & JOHNSON | - | - | - | -66,951 | -100.00% | - | Dec 31, 2023 |
| BARCLAYS PLC | - | - | - | -60,204 | -100.00% | - | Dec 31, 2023 |
| HSBC HOLDINGS PLC | - | - | - | -32,528 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -97,745 | -100.00% | - | Dec 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -63,793 | -100.00% | - | Dec 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -46,778 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -590,687 | -100.00% | - | Dec 31, 2023 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -12,900 | -100.00% | - | Dec 31, 2023 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -277 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -258,746 | -100.00% | - | Dec 31, 2023 |
| BLACKROCK INC. | - | - | - | -153,759 | -100.00% | - | Dec 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -47,966 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -20,039 | -100.00% | - | Dec 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -67,800 | -100.00% | - | Dec 31, 2023 |
Gyre Therapeutics's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -7,052 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -22,484 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -201 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -86,412 | -100.00% | - | Dec 31, 2023 |
| STATE STREET CORP | - | - | - | -72,599 | -100.00% | - | Dec 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -206,900 | -100.00% | - | Dec 31, 2023 |
| JOHNSON & JOHNSON | - | - | - | -66,951 | -100.00% | - | Dec 31, 2023 |
| BARCLAYS PLC | - | - | - | -60,204 | -100.00% | - | Dec 31, 2023 |
| HSBC HOLDINGS PLC | - | - | - | -32,528 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -97,745 | -100.00% | - | Dec 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -63,793 | -100.00% | - | Dec 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -46,778 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -590,687 | -100.00% | - | Dec 31, 2023 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -12,900 | -100.00% | - | Dec 31, 2023 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -277 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -258,746 | -100.00% | - | Dec 31, 2023 |
| BLACKROCK INC. | - | - | - | -153,759 | -100.00% | - | Dec 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -47,966 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -20,039 | -100.00% | - | Dec 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -67,800 | -100.00% | - | Dec 31, 2023 |
The largest Gyre Therapeutics shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Gyre Therapeutics (CBIO), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -22 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -201 | -100.00% | - | Dec 31, 2023 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -277 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -390 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -4,017 | -100.00% | - | Dec 31, 2023 |
| UBS GROUP AG | - | - | - | -5,079 | -100.00% | - | Dec 31, 2023 |
| CUTLER GROUP LLC / CA | - | - | - | -5,500 | -100.00% | - | Dec 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -7,052 | -100.00% | - | Dec 31, 2023 |
| ARETE WEALTH ADVISORS, LLC | - | - | - | -10,845 | -100.00% | - | Dec 31, 2023 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -12,900 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -20,039 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -22,484 | -100.00% | - | Dec 31, 2023 |
| HSBC HOLDINGS PLC | - | - | - | -32,528 | -100.00% | - | Dec 31, 2023 |
| COLORADO CAPITAL MANAGEMENT, INC. | - | - | - | -34,165 | -100.00% | - | Dec 31, 2023 |
| PARALLAX VOLATILITY ADVISERS, L.P. | - | - | - | -43,804 | -100.00% | - | Dec 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -46,778 | -100.00% | - | Dec 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -47,966 | -100.00% | - | Dec 31, 2023 |
| BARCLAYS PLC | - | - | - | -60,204 | -100.00% | - | Dec 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -63,793 | -100.00% | - | Dec 31, 2023 |
| JOHNSON & JOHNSON | - | - | - | -66,951 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Gyre Therapeutics's largest institutional buyer is QUBE RESEARCH & TECHNOLOGIES LTD. The company purchased -22.00 stocks of CBIO, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -590,687 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -258,746 | -100.00% | - | Dec 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -206,900 | -100.00% | - | Dec 31, 2023 |
| BLACKROCK INC. | - | - | - | -153,759 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -97,745 | -100.00% | - | Dec 31, 2023 |
| KYNAM CAPITAL MANAGEMENT, LP | - | - | - | -90,058 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -86,412 | -100.00% | - | Dec 31, 2023 |
| STATE STREET CORP | - | - | - | -72,599 | -100.00% | - | Dec 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -67,800 | -100.00% | - | Dec 31, 2023 |
| JOHNSON & JOHNSON | - | - | - | -66,951 | -100.00% | - | Dec 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -63,793 | -100.00% | - | Dec 31, 2023 |
| BARCLAYS PLC | - | - | - | -60,204 | -100.00% | - | Dec 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -47,966 | -100.00% | - | Dec 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -46,778 | -100.00% | - | Dec 31, 2023 |
| PARALLAX VOLATILITY ADVISERS, L.P. | - | - | - | -43,804 | -100.00% | - | Dec 31, 2023 |
| COLORADO CAPITAL MANAGEMENT, INC. | - | - | - | -34,165 | -100.00% | - | Dec 31, 2023 |
| HSBC HOLDINGS PLC | - | - | - | -32,528 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -22,484 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -20,039 | -100.00% | - | Dec 31, 2023 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -12,900 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Gyre Therapeutics's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -0.59M shares of CBIO, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -590,687 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -258,746 | -100.00% | - | Dec 31, 2023 |
| VANGUARD GROUP INC | - | - | - | -206,900 | -100.00% | - | Dec 31, 2023 |
| BLACKROCK INC. | - | - | - | -153,759 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -97,745 | -100.00% | - | Dec 31, 2023 |
| KYNAM CAPITAL MANAGEMENT, LP | - | - | - | -90,058 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -86,412 | -100.00% | - | Dec 31, 2023 |
| STATE STREET CORP | - | - | - | -72,599 | -100.00% | - | Dec 31, 2023 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | - | - | - | -67,800 | -100.00% | - | Dec 31, 2023 |
| JOHNSON & JOHNSON | - | - | - | -66,951 | -100.00% | - | Dec 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -63,793 | -100.00% | - | Dec 31, 2023 |
| BARCLAYS PLC | - | - | - | -60,204 | -100.00% | - | Dec 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -47,966 | -100.00% | - | Dec 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -46,778 | -100.00% | - | Dec 31, 2023 |
| PARALLAX VOLATILITY ADVISERS, L.P. | - | - | - | -43,804 | -100.00% | - | Dec 31, 2023 |
| COLORADO CAPITAL MANAGEMENT, INC. | - | - | - | -34,165 | -100.00% | - | Dec 31, 2023 |
| HSBC HOLDINGS PLC | - | - | - | -32,528 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -22,484 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -20,039 | -100.00% | - | Dec 31, 2023 |
| RAYMOND JAMES & ASSOCIATES | - | - | - | -12,900 | -100.00% | - | Dec 31, 2023 |
| ARETE WEALTH ADVISORS, LLC | - | - | - | -10,845 | -100.00% | - | Dec 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -7,052 | -100.00% | - | Dec 31, 2023 |
| CUTLER GROUP LLC / CA | - | - | - | -5,500 | -100.00% | - | Dec 31, 2023 |
| UBS GROUP AG | - | - | - | -5,079 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -4,017 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -390 | -100.00% | - | Dec 31, 2023 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -277 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -201 | -100.00% | - | Dec 31, 2023 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -22 | -100.00% | - | Dec 31, 2023 |
Gyre Therapeutics's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -0.59M shares, valued at -, as of undefined.
Gyre Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 23,975 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,003 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 43,138 | - | - | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 41,797 | - | - | Aug 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 255,697 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 24,131 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 137,723 | 117,231 | 572.08% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,540 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 206,900 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 189,757 | -195,793 | -50.78% | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 26,113 | - | - | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 1,486 | - | - | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 11,337 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 182 | - | - | Apr 30, 2021 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 10,815 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 13,113 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 8,488 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 216,440 | - | - | Jan 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 53,464 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 6,662 | 6,662 | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 17,459 | - | - | Mar 28, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,139 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 5,800 | - | - | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 6,436 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 250,852 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 667 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 60,870 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 14,608 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 87,625 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 5,312 | - | - | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 2,141 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,725 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 800 | - | - | Mar 28, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 114,000 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,199 | 3,199 | - | Jan 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,053 | - | - | Dec 31, 2023 |
| TIAA-CREF FUNDS | 0.00% | 49,961 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 7,076 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 297 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,608 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 24,300 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 944 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,329 | - | - | Mar 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 2,050 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 21,959 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 5,711 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,875 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 9,355 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 14,811 | 40 | 0.27% | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 4,208 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,309 | - | - | Mar 31, 2024 |
| John Hancock Funds II | 0.00% | 7,299 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 7,807 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,539 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 2,416 | - | - | Mar 28, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 12 | - | - | Jan 31, 2024 |
Gyre Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 23.98K shares, compromising 0.05% of its total assets.
Gyre Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 23 | 1 | -96.88% |
| 30 Sep, 23 | 32 | 10.34% |
| 30 Jun, 23 | 29 | -21.62% |
| 31 Mar, 23 | 37 | 2.78% |
| 31 Dec, 22 | 36 | 5.88% |
| 30 Sep, 22 | 34 | -15.00% |
| 30 Jun, 22 | 40 | -4.76% |
| 31 Mar, 22 | 42 | -17.65% |
| 31 Dec, 21 | 51 | -25.00% |
| 30 Sep, 21 | 68 | -5.56% |
| 30 Jun, 21 | 72 | -21.74% |
| 31 Mar, 21 | 92 | 10.84% |
| 31 Dec, 20 | 83 | 7.79% |
| 30 Sep, 20 | 77 | -7.23% |
| 30 Jun, 20 | 83 | 69.39% |
| 31 Mar, 20 | 49 | 2.08% |
| 31 Dec, 19 | 48 | 20.00% |
| 30 Sep, 19 | 40 | -25.93% |
| 30 Jun, 19 | 54 | -15.63% |
| 31 Mar, 19 | 64 | -3.03% |
| 31 Dec, 18 | 66 | -13.16% |
| 30 Sep, 18 | 76 | -3.80% |
| 30 Jun, 18 | 79 | 41.07% |
| 31 Mar, 18 | 56 | 100.00% |
| 31 Dec, 17 | 28 | 133.33% |
| 30 Sep, 17 | 12 | -25.00% |
| 30 Jun, 17 | 16 | 6.67% |
| 31 Mar, 17 | 15 | 1400.00% |
| 31 Dec, 16 | 1 | - |
As of 31 Dec 23, 1 institutions are holding Gyre Therapeutics's shares, representing a decrease of -96.88% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 23 | 66 | -100.00% |
| 30 Sep, 23 | 2,152,048 | -5.20% |
| 30 Jun, 23 | 2,270,207 | -32.67% |
| 31 Mar, 23 | 3,371,739 | -32.48% |
| 31 Dec, 22 | 4,993,985 | -35.09% |
| 30 Sep, 22 | 7,693,986 | -4.12% |
| 30 Jun, 22 | 8,024,569 | -17.04% |
| 31 Mar, 22 | 9,672,409 | -35.68% |
| 31 Dec, 21 | 15,037,892 | -18.16% |
| 30 Sep, 21 | 18,375,006 | -9.21% |
| 30 Jun, 21 | 20,239,020 | -9.71% |
| 31 Mar, 21 | 22,415,134 | 56.02% |
| 31 Dec, 20 | 14,367,086 | 1.93% |
| 30 Sep, 20 | 14,095,092 | 1.18% |
| 30 Jun, 20 | 13,931,180 | 29.53% |
| 31 Mar, 20 | 10,755,059 | 42.35% |
| 31 Dec, 19 | 7,555,149 | 1.49% |
| 30 Sep, 19 | 7,443,959 | -0.98% |
| 30 Jun, 19 | 7,517,771 | -7.32% |
| 31 Mar, 19 | 8,111,197 | 9.02% |
| 31 Dec, 18 | 7,440,336 | -5.40% |
| 30 Sep, 18 | 7,865,461 | -2.50% |
| 30 Jun, 18 | 8,067,155 | -5.37% |
| 31 Mar, 18 | 8,524,918 | 229.43% |
| 31 Dec, 17 | 2,587,756 | 106.14% |
| 30 Sep, 17 | 1,255,367 | 6.38% |
| 30 Jun, 17 | 1,180,050 | 545.99% |
| 31 Mar, 17 | 182,673 | 20219.58% |
| 31 Dec, 16 | 899 | - |
Gyre Therapeutics (CBIO) has 66.00 shares outstanding as of 31 Dec 23, down -100.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 23 | 0.00% | - |
| 30 Sep, 23 | 84.95% | 1.05% |
| 30 Jun, 23 | 90.02% | 0.50% |
| 31 Mar, 23 | 134.16% | 0.24% |
| 31 Dec, 22 | 237.39% | 0.17% |
| 30 Sep, 22 | 378.08% | 0.26% |
| 30 Jun, 22 | 382.40% | 0.18% |
| 31 Mar, 22 | 461.23% | 0.09% |
| 31 Dec, 21 | 736.17% | 0.10% |
| 30 Sep, 21 | 878.35% | 0.09% |
| 30 Jun, 21 | 974.98% | 0.07% |
| 31 Mar, 21 | 1184.51% | 0.09% |
| 31 Dec, 20 | 1123.64% | 0.12% |
| 30 Sep, 20 | 957.88% | 0.07% |
| 30 Jun, 20 | 1167.97% | 0.10% |
| 31 Mar, 20 | 1105.54% | 0.12% |
| 31 Dec, 19 | 944.04% | 0.11% |
| 30 Sep, 19 | 928.74% | 0.10% |
| 30 Jun, 19 | 940.52% | 0.09% |
| 31 Mar, 19 | 1016.99% | 0.10% |
| 31 Dec, 18 | 995.24% | 0.10% |
| 30 Sep, 18 | 987.90% | 0.10% |
| 30 Jun, 18 | 1013.60% | 0.05% |
| 31 Mar, 18 | 1422.45% | 0.20% |
| 31 Dec, 17 | 850.52% | 0.45% |
| 30 Sep, 17 | 436.85% | 0.21% |
| 30 Jun, 17 | 456.47% | 9.14% |
| 31 Mar, 17 | 70.66% | 259.70% |
| 31 Dec, 16 | 5.22% | - |
As of 31 Dec 23, Gyre Therapeutics is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 23 | 1 | -92.31% |
| 30 Sep, 23 | 13 | 62.50% |
| 30 Jun, 23 | 8 | -55.56% |
| 31 Mar, 23 | 18 | 38.46% |
| 31 Dec, 22 | 13 | 18.18% |
| 30 Sep, 22 | 11 | 22.22% |
| 30 Jun, 22 | 9 | -10.00% |
| 31 Mar, 22 | 10 | -54.55% |
| 31 Dec, 21 | 22 | - |
| 30 Sep, 21 | 22 | -24.14% |
| 30 Jun, 21 | 29 | -51.67% |
| 31 Mar, 21 | 60 | 25.00% |
| 31 Dec, 20 | 48 | 14.29% |
| 30 Sep, 20 | 42 | -25.00% |
| 30 Jun, 20 | 56 | 86.67% |
| 31 Mar, 20 | 30 | 50.00% |
| 31 Dec, 19 | 20 | 17.65% |
| 30 Sep, 19 | 17 | -45.16% |
| 30 Jun, 19 | 31 | 6.90% |
| 31 Mar, 19 | 29 | -19.44% |
| 31 Dec, 18 | 36 | -14.29% |
| 30 Sep, 18 | 42 | -31.15% |
| 30 Jun, 18 | 61 | 29.79% |
| 31 Mar, 18 | 47 | 104.35% |
| 31 Dec, 17 | 23 | 283.33% |
| 30 Sep, 17 | 6 | -57.14% |
| 30 Jun, 17 | 14 | 16.67% |
| 31 Mar, 17 | 12 | 1100.00% |
| 31 Dec, 16 | 1 | - |
1 institutional shareholders have increased their position in CBIO stock as of 31 Dec 23 compared to 13 in the previous quarter (a -92.31% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 23 | - | -100.00% |
| 30 Sep, 23 | 7 | -12.50% |
| 30 Jun, 23 | 8 | 60.00% |
| 31 Mar, 23 | 5 | -64.29% |
| 31 Dec, 22 | 14 | 75.00% |
| 30 Sep, 22 | 8 | -50.00% |
| 30 Jun, 22 | 16 | -11.11% |
| 31 Mar, 22 | 18 | 12.50% |
| 31 Dec, 21 | 16 | -50.00% |
| 30 Sep, 21 | 32 | 6.67% |
| 30 Jun, 21 | 30 | 66.67% |
| 31 Mar, 21 | 18 | - |
| 31 Dec, 20 | 18 | -5.26% |
| 30 Sep, 20 | 19 | 11.76% |
| 30 Jun, 20 | 17 | 88.89% |
| 31 Mar, 20 | 9 | -55.00% |
| 31 Dec, 19 | 20 | 25.00% |
| 30 Sep, 19 | 16 | -5.88% |
| 30 Jun, 19 | 17 | -29.17% |
| 31 Mar, 19 | 24 | 26.32% |
| 31 Dec, 18 | 19 | 11.76% |
| 30 Sep, 18 | 17 | 112.50% |
| 30 Jun, 18 | 8 | 300.00% |
| 31 Mar, 18 | 2 | -50.00% |
| 31 Dec, 17 | 4 | - |
| 30 Sep, 17 | 4 | 300.00% |
| 30 Jun, 17 | 1 | - |
| 31 Mar, 17 | 1 | - |
| 31 Dec, 16 | - | - |
- institutional shareholders have reduced their position in CBIO stock as of 31 Dec 23 compared to 7 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 23 | 1 | -96.88% | 66 | -100.00% | 0.00% | - | 1 | -92.31% | - | -100.00% |
| 30 Sep, 23 | 32 | 10.34% | 2,152,048 | -5.20% | 84.95% | 1.05% | 13 | 62.50% | 7 | -12.50% |
| 30 Jun, 23 | 29 | -21.62% | 2,270,207 | -32.67% | 90.02% | 0.50% | 8 | -55.56% | 8 | 60.00% |
| 31 Mar, 23 | 37 | 2.78% | 3,371,739 | -32.48% | 134.16% | 0.24% | 18 | 38.46% | 5 | -64.29% |
| 31 Dec, 22 | 36 | 5.88% | 4,993,985 | -35.09% | 237.39% | 0.17% | 13 | 18.18% | 14 | 75.00% |
| 30 Sep, 22 | 34 | -15.00% | 7,693,986 | -4.12% | 378.08% | 0.26% | 11 | 22.22% | 8 | -50.00% |
| 30 Jun, 22 | 40 | -4.76% | 8,024,569 | -17.04% | 382.40% | 0.18% | 9 | -10.00% | 16 | -11.11% |
| 31 Mar, 22 | 42 | -17.65% | 9,672,409 | -35.68% | 461.23% | 0.09% | 10 | -54.55% | 18 | 12.50% |
| 31 Dec, 21 | 51 | -25.00% | 15,037,892 | -18.16% | 736.17% | 0.10% | 22 | - | 16 | -50.00% |
| 30 Sep, 21 | 68 | -5.56% | 18,375,006 | -9.21% | 878.35% | 0.09% | 22 | -24.14% | 32 | 6.67% |
| 30 Jun, 21 | 72 | -21.74% | 20,239,020 | -9.71% | 974.98% | 0.07% | 29 | -51.67% | 30 | 66.67% |
| 31 Mar, 21 | 92 | 10.84% | 22,415,134 | 56.02% | 1184.51% | 0.09% | 60 | 25.00% | 18 | - |
| 31 Dec, 20 | 83 | 7.79% | 14,367,086 | 1.93% | 1123.64% | 0.12% | 48 | 14.29% | 18 | -5.26% |
| 30 Sep, 20 | 77 | -7.23% | 14,095,092 | 1.18% | 957.88% | 0.07% | 42 | -25.00% | 19 | 11.76% |
| 30 Jun, 20 | 83 | 69.39% | 13,931,180 | 29.53% | 1167.97% | 0.10% | 56 | 86.67% | 17 | 88.89% |
| 31 Mar, 20 | 49 | 2.08% | 10,755,059 | 42.35% | 1105.54% | 0.12% | 30 | 50.00% | 9 | -55.00% |
| 31 Dec, 19 | 48 | 20.00% | 7,555,149 | 1.49% | 944.04% | 0.11% | 20 | 17.65% | 20 | 25.00% |
| 30 Sep, 19 | 40 | -25.93% | 7,443,959 | -0.98% | 928.74% | 0.10% | 17 | -45.16% | 16 | -5.88% |
| 30 Jun, 19 | 54 | -15.63% | 7,517,771 | -7.32% | 940.52% | 0.09% | 31 | 6.90% | 17 | -29.17% |
| 31 Mar, 19 | 64 | -3.03% | 8,111,197 | 9.02% | 1016.99% | 0.10% | 29 | -19.44% | 24 | 26.32% |
| 31 Dec, 18 | 66 | -13.16% | 7,440,336 | -5.40% | 995.24% | 0.10% | 36 | -14.29% | 19 | 11.76% |
| 30 Sep, 18 | 76 | -3.80% | 7,865,461 | -2.50% | 987.90% | 0.10% | 42 | -31.15% | 17 | 112.50% |
| 30 Jun, 18 | 79 | 41.07% | 8,067,155 | -5.37% | 1013.60% | 0.05% | 61 | 29.79% | 8 | 300.00% |
| 31 Mar, 18 | 56 | 100.00% | 8,524,918 | 229.43% | 1422.45% | 0.20% | 47 | 104.35% | 2 | -50.00% |
| 31 Dec, 17 | 28 | 133.33% | 2,587,756 | 106.14% | 850.52% | 0.45% | 23 | 283.33% | 4 | - |
| 30 Sep, 17 | 12 | -25.00% | 1,255,367 | 6.38% | 436.85% | 0.21% | 6 | -57.14% | 4 | 300.00% |
| 30 Jun, 17 | 16 | 6.67% | 1,180,050 | 545.99% | 456.47% | 9.14% | 14 | 16.67% | 1 | - |
| 31 Mar, 17 | 15 | 1400.00% | 182,673 | 20219.58% | 70.66% | 259.70% | 12 | 1100.00% | 1 | - |
| 31 Dec, 16 | 1 | - | 899 | - | 5.22% | - | 1 | - | - | - |
Gyre Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
All Insider Owners Trades
Gyre Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | 19 | 2 | 950.00% |
| Q3 2023 | - | 5 | - |
| Q4 2022 | - | 3 | - |
| Q3 2022 | 3 | - | - |
| Q1 2022 | 8 | - | - |
| Q4 2021 | 5 | 1 | 500.00% |
| Q3 2021 | 9 | 7 | 128.57% |
| Q2 2021 | 12 | 1 | 1200.00% |
| Q1 2021 | 13 | - | - |
| Q4 2020 | 5 | - | - |
| Q3 2020 | 9 | - | - |
| Q2 2020 | 12 | - | - |
| Q1 2020 | 18 | 1 | 1800.00% |
| Q4 2019 | 4 | - | - |
| Q3 2019 | 7 | 2 | 350.00% |
| Q2 2019 | 13 | 4 | 325.00% |
| Q1 2019 | 9 | 3 | 300.00% |
| Q4 2018 | 6 | 3 | 200.00% |
| Q3 2018 | 3 | 2 | 150.00% |
| Q2 2018 | 9 | 3 | 300.00% |
19 total buy trades, and 2 total sell trades (buy/sell ratio of 9.50%) were made by Gyre Therapeutics's insiders, as of Q4 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | 2 | - | - |
| Q3 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | 3 | - | - |
| Q1 2022 | 3 | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | 3 | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | 2 | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 2 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | 6 | 1 | 600.00% |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | 1 | - | - |
| Q1 2019 | - | - | - |
| Q4 2018 | - | 1 | - |
| Q3 2018 | - | - | - |
| Q2 2018 | - | - | - |
As of Q4 2023, Insider owners conducted 2 open market buy trades and 0 open market sell trades of Gyre Therapeutics's stocks.
CBIO Ownership FAQ
Who Owns Gyre Therapeutics?
Gyre Therapeutics is owned by institutional shareholders (0.00%), insiders (27.73%), and public (72.26%). The largest institutional shareholder of Gyre Therapeutics is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.05% of total shares).
Who are the major institutional shareholders of Gyre Therapeutics?
Gyre Therapeutics's major institutional shareholders are JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, and STATE STREET CORP. The top five shareholders own together 0% of the company's share outstanding.
How many Gyre Therapeutics shareholders are there?
As of Dec 2023, there are 1 institutional shareholders of Gyre Therapeutics.
What percentage of Gyre Therapeutics is owned by JPMORGAN CHASE & CO?
JPMORGAN CHASE & CO owns 0 shares of Gyre Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).
What percentage of Gyre Therapeutics is owned by BANK OF AMERICA CORP /DE/?
As of Dec 2023, BANK OF AMERICA CORP /DE/ holds 0 shares of Gyre Therapeutics (CBIO), compromising 0% of the company, valued at $0.
What percentage of Gyre Therapeutics is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN is the third largest holder of Gyre Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).